AF
GILD icon

Allworth Financial’s Gilead Sciences GILD Stock Holding History

Allworth Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.96M Sell
47,192
-8,687
-16% -$1.14M 0.03% 316
2026
Q1 		$7.79M Buy
55,879
+6,200
+12% +$868K 0.03% 291
2025
Q4 		$6.1M Buy
49,679
+1,593
+3% +$194K 0.03% 322
2025
Q3 		$5.34M Buy
48,086
+1,885
+4% +$214K 0.02% 305
2025
Q2 		$5.12M Buy
46,201
+4,208
+10% +$448K 0.02% 301
2025
Q1 		$4.46M Buy
41,993
+6,040
+17% +$623K 0.03% 271
2024
Q4 		$3.35M Buy
35,953
+7,143
+25% +$643K 0.02% 320
2024
Q3 		$2.42M Sell
28,810
-157
-0.5% -$12K 0.01% 307
2024
Q2 		$2.1M Sell
28,967
-4,228
-13% -$282K 0.01% 327
2024
Q1 		$2.43M Sell
33,195
-5,439
-14% -$418K 0.02% 291
2023
Q4 		$3.13M Sell
38,634
-1,171
-3% -$91.1K 0.02% 243
2023
Q3 		$2.98M Buy
39,805
+5,665
+17% +$436K 0.03% 231
2023
Q2 		$2.63M Buy
34,140
+13,111
+62% +$1.05M 0.02% 248
2023
Q1 		$1.74M Buy
21,029
+2,383
+13% +$197K 0.02% 276
2022
Q4 		$1.6M Sell
18,646
-324
-2% -$25.7K 0.02% 275
2022
Q3 		$1.17M Buy
18,970
+3,888
+26% +$245K 0.01% 296
2022
Q2 		$932K Buy
15,082
+1,011
+7% +$62.6K 0.01% 316
2022
Q1 		$837K Sell
14,071
-165
-1% -$10.5K 0.01% 328
2021
Q4 		$1.03M Sell
14,236
-759
-5% -$52.3K 0.01% 279
2021
Q3 		$1.05M Buy
14,995
+13,133
+705% +$923K 0.02% 232
2021
Q2 		$128K Sell
1,862
-638
-26% -$42.6K ﹤0.01% 440
2021
Q1 		$162K Sell
2,500
-248
-9% -$16K ﹤0.01% 379
2020
Q4 		$160K Buy
2,748
+296
+12% +$17.9K ﹤0.01% 308
2020
Q3 		$155K Buy
2,452
+51
+2% +$3.54K ﹤0.01% 270
2020
Q2 		$185K Buy
2,401
+251
+12% +$19.2K 0.01% 246
2020
Q1 		$161K Sell
2,150
-37
-2% -$2.56K 0.01% 260
2019
Q4 		$142K Buy
2,187
+244
+13% +$15.9K 0.01% 224
2019
Q3 		$123K Buy
1,943
+530
+38% +$34.6K ﹤0.01% 213
2019
Q2 		$95K Sell
1,413
-53
-4% -$3.49K ﹤0.01% 243
2019
Q1 		$95K Buy
1,466
+280
+24% +$18.6K ﹤0.01% 242
2018
Q4 		$74K Buy
1,186
+18
+2% +$1.26K ﹤0.01% 245
2018
Q3 		$90K Buy
1,168
+37
+3% +$2.79K ﹤0.01% 222
2018
Q2 		$80K Buy
1,131
+109
+11% +$7.7K ﹤0.01% 223
2018
Q1 		$77K Sell
1,022
-3
-0.3% -$238 0.01% 201
2017
Q4 		$73K Buy
1,025
+7
+0.7% +$532 0.01% 199
2017
Q3 		$82K Hold
1,018
– – 0.01% 182
2017
Q2 		$72K Buy
1,018
+5
+0.5% +$333 0.01% 208
2017
Q1 		$69K Buy
1,013
+13
+1% +$914 0.01% 201
2016
Q4 		$72K Sell
1,000
-123
-11% -$9.14K 0.01% 181
2016
Q3 		$89K Sell
1,123
-457
-29% -$37.1K 0.01% 160
2016
Q2 		$132K Sell
1,580
-506
-24% -$44.9K 0.01% 120
2016
Q1 		$192K Buy
2,086
+506
+32% +$45.6K 0.02% 98
2015
Q4 		$160K Sell
1,580
-106
-6% -$11K 0.03% 106
2015
Q3 		$166K Buy
1,686
+686
+69% +$76.2K 0.06% 94
2015
Q2 		$117K Sell
1,000
-275
-22% -$30K 0.04% 125
2015
Q1 		$125K Buy
+1,275
New +$129K 0.05% 119

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Allworth Financial's GILD Position: Q2 2026 in Review

Allworth Financial reduced its Gilead Sciences (GILD) stake by 16% in Q2 2026, selling an estimated $1.14M and leaving 47,192 shares worth $5.96M. The position accounts for 0.03% of the portfolio, ranked #316.

Allworth Financial first reported a position in GILD in Q1 2015 and has held it in 46 quarters since. The position peaked at $7.79M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Allworth Financial held 47,192 shares of Gilead Sciences worth $5.96M as of Q2 2026.
  • Allworth Financial sold 8,687 Gilead Sciences shares in Q2 2026, an estimated $1.14M.
  • Gilead Sciences made up 0.03% of Allworth Financial's portfolio in Q2 2026, its #316 holding.
  • Allworth Financial first reported a position in Gilead Sciences in Q1 2015 and has held it in 46 quarters since.
  • Allworth Financial's Gilead Sciences position peaked at $7.79M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.